Bill > S1355

This bill, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023 or the PASTEUR Act of 2023, establishes a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections. It creates a Committee on Critical Need Antimicrobials to develop a list of infections for which new antimicrobial drug development is needed, establish regulations for a subscription contract program, and appoint a Critical Need Antimicrobial Advisory Group. The bill also provides for transitional subscription contracts, the designation of antimicrobial drugs as "critical need," the establishment of a Subscription Contract Office, and requirements for appropriate use, reporting, and supply chain management of critical need antimicrobials. Additionally, the bill funds efforts to encourage appropriate antimicrobial use and combat resistance, and requires studies and reports on the effectiveness of the program.